SRC as a novel therapeutic target fot the treatment of triple negative breast cancer (TNBC)

被引：0
|
作者：
Walsh, S. [1 ]
Tryfonopoulos, D. [2 ,3 ]
Quinn, C. [4 ]
Flanagan, L. [4 ]
Pierce, A. [1 ]
McDermott, E. W. [1 ]
Evoy, D. [1 ]
O'Donovan, N. [2 ]
Crown, J. [2 ,3 ]
Duffy, M. J. [1 ,4 ]
机构：
[1] Univ Coll Dublin, UCD Sch Med & Med Sci, Dublin 2, Ireland
[2] Dublin City Univ, NICB, Dublin 9, Ireland
[3] St Vincents Univ Hosp, Dept Med Oncol, Dublin 4, Ireland
[4] St Vincents Univ Hosp, Dept Pathol & Lab Med, Dublin 4, Ireland
来源：
BRITISH JOURNAL OF SURGERY | 2011年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [41] Notch-4 is a novel therapeutic target and prognostic marker for triple negative breast cancer
    Kai, M.
    Mori, H.
    Yamada, M.
    Kubo, M.
    Nakamura, M.
    BREAST, 2017, 32 : S96 - S96
  • [42] ERRβ: Validating a novel target for triple negative breast cancer
    Fernandez, Aileen I.
    Graham, Garrett
    Gyorffy, Balazs
    Cavalli, Luciane
    Riggins, Rebecca B.
    CANCER RESEARCH, 2017, 77
  • [43] THE WNT SIGNALING CASCADE AS A POTENTIAL NOVEL BIOMARKER OF TRIPLE NEGATIVE BREAST CANCER (TNBC)
    Huelsewig, C.
    Ruckert, C.
    Goette, M.
    von Wahlde, M. K.
    Buchweitz, O.
    Kiesel, L.
    Pusztai, L.
    Liedtke, C.
    ANNALS OF ONCOLOGY, 2011, 22 : 51 - 51
  • [44] Mesothelin, a novel immunotherapy target for triple negative breast cancer
    Tchou, Julia
    Wang, Liang-Chuan
    Selven, Ben
    Zhang, Hongtao
    Conejo-Garcia, Jose
    Borghaei, Hossein
    Kalos, Michael
    Vondeheide, Robert H.
    Albelda, Steven M.
    June, Carl H.
    Zhang, Paul J.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (02) : 799 - 804
  • [45] Mesothelin, a novel immunotherapy target for triple negative breast cancer
    Julia Tchou
    Liang-Chuan Wang
    Ben Selven
    Hongtao Zhang
    Jose Conejo-Garcia
    Hossein Borghaei
    Michael Kalos
    Robert H. Vondeheide
    Steven M. Albelda
    Carl H. June
    Paul J. Zhang
    Breast Cancer Research and Treatment, 2012, 133 : 799 - 804
  • [46] RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer
    My-my Huynh
    Jayanthan, Aarthi
    Pambid, Mary Rose
    Los, Gerrit
    Dunn, Sandra E.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (01) : 1 - 5
  • [47] Mutant p53 as a Therapeutic Target for the Treatment of Triple-Negative Breast Cancer
    Synnott, N.
    Crown, J.
    Duffy, M. J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E41 - E41
  • [48] Loss-of-function screening identifies therapeutic targets for triple negative breast cancer (TNBC)
    Bauer, Joshua A.
    Lehmann, Brian D.
    Glick, Gloria
    Cortez, David
    Lee, Ethan
    Pietenpol, Jennifer A.
    CANCER RESEARCH, 2011, 71
  • [49] The wnt/β-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer
    King, Taj D.
    Suto, Mark J.
    Li, Yonghe
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2012, 113 (01) : 13 - 18
  • [50] Mutant p53: A therapeutic target for the treatment of triple-negative breast cancer?
    Synnott, Naoise C.
    Pierce, Aisling
    Mullooly, Maeve
    Caiazza, Francesco
    McGowan, Patricia M.
    O'Donovan, Norma
    Crown, John
    Duffy, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345